We are live on ! Find out more
JSMC

Jess S. Morgan & Co Portfolio holdings

AUM $115M
1-Year Est. Return 16.65%
This Fund
S&P 500
This Quarter Est. Return
+12.89%
1 Year Est. Return
-16.65%
3 Year Est. Return
+69.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$9.45M
Cap. Flow
-$4.94M
Cap. Flow %
-3.24%
Top 10 Hldgs %
32.37%
Holding
44
New
–
Increased
28
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
CKPT
Checkpoint Therapeutics
CKPT
+$1.47M
2
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$971K
3
AXSM icon
Axsome Therapeutics
AXSM
+$911K
4
AGEN
Agenus
AGEN
+$660K
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$577K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.35M
2
PARA
Paramount Global Class B
PARA
+$2.56M
3
MNOV icon
MediciNova
MNOV
+$2.52M
4
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$2.28M
5
ORMP icon
Oramed Pharmaceuticals
ORMP
+$660K

Sector Composition

Rank Sector Weight
1 Healthcare 24.89%
2 Technology 11.42%
3 Financials 8.35%
4 Consumer Discretionary 5.21%
5 Consumer Staples 2.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
Invesco QQQ Trust
QQQ
$450B
$5.41M 3.55%
15,255
+239
+2% +$80.4K
TNA icon
2
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.31B
$5.29M 3.48%
54,051
-1,392
-3% -$130K
NVCR icon
3
NovoCure
NVCR
$2.04B
$5.27M 3.47%
23,775
-2,207
-8% -$429K
IWV icon
4
iShares Russell 3000 ETF
IWV
$19.4B
$5M 3.28%
19,517
+278
+1% +$69.3K
XLF icon
5
State Street Financial Select Sector SPDR ETF
XLF
$56.1B
$4.75M 3.12%
129,479
-4,222
-3% -$154K
FDN icon
6
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.86B
$4.75M 3.12%
19,389
+425
+2% +$97.2K
IYJ icon
7
iShares US Industrials ETF
IYJ
$1.98B
$4.73M 3.11%
42,600
+158
+0.4% +$17.4K
AAPL icon
8
Apple
AAPL
$4.89T
$4.73M 3.11%
34,516
+2,190
+7% +$284K
SOXX icon
9
iShares Semiconductor ETF
SOXX
$43.6B
$4.72M 3.11%
31,209
+528
+2% +$75.5K
VCR icon
10
Vanguard Consumer Discretionary ETF
VCR
$5.84B
$4.6M 3.03%
14,658
+74
+0.5% +$22.7K
AXSM icon
11
Axsome Therapeutics
AXSM
$12.4B
$4.58M 3.01%
67,835
+15,177
+29% +$911K
INTU icon
12
Intuit
INTU
$81.1B
$4.54M 2.98%
9,261
-397
-4% -$172K
KRE icon
13
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$4.46M 2.93%
68,004
-355
-0.5% -$24.3K
XBI icon
14
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$4.38M 2.88%
32,352
+4,392
+16% +$577K
BAC icon
15
Bank of America
BAC
$435B
$4.32M 2.84%
104,856
-6,694
-6% -$274K
ORMP icon
16
Oramed Pharmaceuticals
ORMP
$165M
$4.31M 2.83%
322,249
-57,695
-15% -$660K
AGEN
17
Agenus
AGEN
$249M
$4.29M 2.82%
39,771
+8,799
+28% +$660K
JPM icon
18
JPMorgan Chase
JPM
$939B
$4.26M 2.8%
27,374
-328
-1% -$51.5K
AMZN icon
19
Amazon
AMZN
$2.5T
$4.17M 2.74%
24,260
+1,580
+7% +$263K
ADBE icon
20
Adobe
ADBE
$89.5B
$4.13M 2.72%
7,055
+207
+3% +$107K
BLK icon
21
Blackrock
BLK
$164B
$4.13M 2.71%
4,718
-254
-5% -$215K
UNH icon
22
UnitedHealth
UNH
$382B
$4.11M 2.7%
10,256
-3
-0% -$1.2K
PEP icon
23
PepsiCo
PEP
$186B
$4.09M 2.69%
27,596
+1,455
+6% +$212K
HON icon
24
Honeywell
HON
$77.1B
$4.06M 2.67%
19,659
+897
+5% +$190K
TMO icon
25
Thermo Fisher Scientific
TMO
$211B
$4.04M 2.66%
8,010
+821
+11% +$387K
1
2

Similar funds

RCM
Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return
DIV
DCM International VI Menlo Park, California $114M AUM 73.96% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
FFC
Fure Financial Corporation Bloomington, Minnesota $122M AUM 1.51% 1-Year Est. Return
SA
SWM Advisors St. Petersburg, Florida $106M AUM 17.51% 1-Year Est. Return
MCA
Morris Capital Advisors Malvern, Pennsylvania $106M AUM 2.55% 1-Year Est. Return
SCM
Salem Capital Management Woburn, Massachusetts $126M AUM 8.82% 1-Year Est. Return
LAM
LFS Asset Management San Ramon, California $99.1M AUM

Jess S. Morgan & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Jess S. Morgan & Co held 44 positions worth $152M, up 6.6% from $143M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jess S. Morgan & Co withdrew a net $4.94M in Q2 2021, closing 4 positions and reducing 12 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $3.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Jess S. Morgan & Co added an estimated $1.47M to Checkpoint Therapeutics.

  • Jess S. Morgan & Co added most to Checkpoint Therapeutics in Q2 2021, an estimated $1.47M increase.
  • Jess S. Morgan & Co's biggest Q2 2021 reduction was Oramed Pharmaceuticals, cutting an estimated $660K.
  • Jess S. Morgan & Co fully exited Bristol-Myers Squibb in Q2 2021, selling an estimated $3.35M.
  • Jess S. Morgan & Co's ten largest holdings make up 32% of its $152M portfolio in Q2 2021.
  • Jess S. Morgan & Co opened 0 new positions and closed 4 in Q2 2021.
  • Jess S. Morgan & Co's portfolio value rose 6.6% quarter-over-quarter to $152M.

Based on Jess S. Morgan & Co's 13F filing for Q2 2021, filed 30 Nov 2021.